Our research is focused on investigating the underlying mechanisms of disease using molecularly targeted imaging agents. We develop and utilize methodologies for imaging diseases such as multiple myeloma with high sensitivity and specificity. Our imaging probes are based on peptides, nanoparticles and antibodies; which combined with nuclear, optical, and magnetic resonance imaging platforms confer information in nano-, meso- and micro- scale. Our interdisciplinary group is involved in various aspects of bench to bedside translation. We are fundamentally dedicated to Education, Diversity, Discovery, Innovation and Clinical Translation.